BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3282009)

  • 1. Proteolytic cleavage of Ii to p25.
    Thomas LJ; Nguyen QV; Elliott WL; Humphreys RE
    J Immunol; 1988 Apr; 140(8):2670-4. PubMed ID: 3282009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
    Spiro RC; Sairenji T; Humphreys RE
    J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of DR molecules from complexes with invariant chain through the formation of a C-terminal 25 kDa invariant chain fragment.
    Demotz S; Danieli C
    Mol Immunol; 1993 Dec; 30(18):1623-32. PubMed ID: 8272076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invariant chain associates with HLA class II antigens via its extracytoplasmic region.
    Marks MS; Cresswell P
    J Immunol; 1986 Apr; 136(7):2519-25. PubMed ID: 3512715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of invariant chain subsets as a function of their association with MHC class II chains.
    Nguyen QV; Reyes VE; Humphreys RE
    Arch Biochem Biophys; 1995 Feb; 317(1):128-32. PubMed ID: 7872774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine Ia-associated invariant chain's processing to complex oligosaccharide forms and its dissociation from the I-Ak complex.
    Holt GD; Swiedler SJ; Freed JH; Hart GW
    J Immunol; 1985 Jul; 135(1):399-407. PubMed ID: 3873494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of fragments of the murine Ia-associated invariant chain.
    Mehringer JH; Harris MR; Kindle CS; McCourt DW; Cullen SE
    J Immunol; 1991 Feb; 146(3):920-7. PubMed ID: 1988503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L; Kovats S; Eastman S; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
    Cheng PC; Steele CR; Gu L; Song W; Pierce SK
    J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner.
    Lautwein A; Kraus M; Reich M; Burster T; Brandenburg J; Overkleeft HS; Schwarz G; Kammer W; Weber E; Kalbacher H; Nordheim A; Driessen C
    J Leukoc Biol; 2004 May; 75(5):844-55. PubMed ID: 14966190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
    Hitzel C; van Endert P; Koch N
    J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers.
    Hmama Z; Gabathuler R; Jefferies WA; de Jong G; Reiner NE
    J Immunol; 1998 Nov; 161(9):4882-93. PubMed ID: 9794422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of intracellular associations, processing, and cleavages of Ii forms and class II major histocompatibility complex molecules.
    Nguyen QV; Humphreys RE
    J Biol Chem; 1989 Jan; 264(3):1631-7. PubMed ID: 2783582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
    Schafer PH; Green JM; Malapati S; Gu L; Pierce SK
    J Immunol; 1996 Dec; 157(12):5487-95. PubMed ID: 8955198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
    Thayer WP; Ignatowicz L; Weber DA; Jensen PE
    J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
    Zechel MA; Chaturvedi P; Lee-Chan EC; Rider BJ; Singh B
    J Immunol; 1996 Jun; 156(11):4232-9. PubMed ID: 8666792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The invariant chain is a phosphorylated subunit of class II molecules.
    Spiro RC; Quaranta V
    J Immunol; 1989 Oct; 143(8):2589-94. PubMed ID: 2507633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.